|
|
|
 |
| |
|
| |
|
Synthetic molecules that can bind with
high sequence specificity to a chosen target in a gene
sequence are of major interest in medicinal and
biotechnological contexts. They show promise for the
development of gene therapeutic agents, diagnostic
devices for genetic analysis, and as molecular tools for
nucleic acid manipulations.
Our experience in
PNA/DNA chimera synthesis allows us to offer the
synthesis of a chimera at competitive prices and quick
delivery.
BioSynthesis offers the following hybrid chimeric PNA synthesis with following possible combinations::
Possible Combination |
| |
DNA |
RNA |
2'O-Me- RNA |
2'-F-RNA |
LNA |
PNA |
Peptide |
| DNA |
|
|
x |
* |
x |
* |
x |
* |
x |
* |
x |
x |
| RNA |
x |
* |
|
|
x |
* |
x |
* |
x |
* |
x |
x |
| 2'-O-Me- RNA |
x |
* |
x |
* |
|
|
x |
* |
x |
* |
x |
x |
| 2'-F-RNA |
x |
* |
x |
* |
x |
* |
|
|
x |
* |
x |
x |
| LNA |
x |
* |
x |
* |
x |
* |
x |
* |
|
|
x |
x |
| PNA |
x |
* |
x |
* |
x |
* |
x |
* |
x |
* |
|
x |
| Peptide |
x |
* |
x |
* |
x |
* |
x |
* |
x |
* |
x |
|
- *PO - phosphodiester; PS - phosphorothioate, MPN - methylphosphonate
- *Guarantee is for 20 mers or longer. Shorter oligos may have fewer ODs.
- Please refer to our large-scale services for quanity >10 gram
|
For further information contact our team or click here for price quote |
| |
|
|
|
|
